Cellectar Biosciences
Price & Volume
Stats
See moreOpen | $1.48 |
Previous Close | $1.39 |
Day Range | $1.18-$1.48 |
52W Range | $1.34-$5.06 |
Market Cap | $13.5M |
Shares Short | 166,265 |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$3.48 |
News
See moreYahoo Finance • 2 months ago
Cellectar Reports Q2 2026 Results, Strengthened Cash Positions Supports Oncology Pipeline
Yahoo Finance • 2 months ago
Cellectar Biosciences Q2 2026 Earnings Preview
Yahoo Finance • 3 months ago
Cellectar Biosciences Announces Publication of Phase 1 Study of Iopofosine I 131 in Peer-Reviewed Journal Cancers
About
CEO | Mr. James V. Caruso |
CFO | Mr. Chad J. Kolean CPA |
Address | 100 Campus Drive, Florham Park, NJ, United States, 07932 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 11 |